Alopecia areata was more likely to develop in patients with inflammatory bowel disease (IBD) who were taking anti–tumor necrosis factor (TNF) therapy at the onset of the condition.
While most previously reported cases have described localized hair loss confined to the site of the tick attachment, this particular case presents a notable departure from that pattern, revealing ...
Why are we all so scared of it? I’m led to believe that Black women and femmes with alopecia aren’t the only ones affected by the disability. Maybe all Black women, especially those of us who ...
Alopecia areata. This is an autoimmune disease that ... It’s a common cause of hair thinning in women. Telogen effluvium forces your hair into the telogen phase, the final phase of your hair ...
Pfizer’s JAK/TEC inhibitor Litfulo has been recommended for NHS use as a treatment for hair loss caused by severe alopecia areata, the first drug therapy for a condition that affects around ...
A new study published in the journal of Dermatology suggests that the Alopecia areata patients who were receiving doses of active ritlecitinib reported better outcomes in terms of satisfaction with ...
Here's some hard truth: One-third of women will experience hair loss at ... genetics aren’t the only risk factor: alopecia areata is a form of hair loss that appears as patchy bald spots and ...
Alopecia areata is a disorder in which the body reacts against itself, an 'auto immune disorder', causing patches of hair to fall out. It can start at any age but is most likely to start in childhood.